EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.20.4.3 | Infections |
31731720 |
Mycoredoxins Are Required for Redox Homeostasis and Intracellular Survival in the Actinobacterial Pathogen Rhodococcus equi. |
causal interaction
unassigned |
3
0 |
| 1.20.4.3 | Infections |
34483223 |
Involvement of a mycothiol-dependent reductase NCgl0018 in oxidative stress response of Corynebacterium glutamicum. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
2
2
0 |
| 1.20.4.3 | Tuberculosis |
11567012 |
The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis. |
unassigned |
0 |
| 1.20.4.3 | Tuberculosis |
22970802 |
Mycoredoxin-1 is one of the missing links in the oxidative stress defense mechanism of Mycobacteria. |
ongoing research
unassigned |
1
0 |
| 1.20.4.3 | Tuberculosis |
24379404 |
Mycothiol/mycoredoxin 1-dependent reduction of the peroxiredoxin AhpE from Mycobacterium tuberculosis. |
ongoing research
therapeutic application
unassigned |
1
3
0 |
| 1.20.4.3 | Tuberculosis |
24877756 |
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis. |
therapeutic application
unassigned |
1
0 |
| 1.20.4.3 | Tuberculosis |
26546681 |
The Redox State Regulates the Conformation of Rv2466c to Activate the Antitubercular Prodrug TP053. |
therapeutic application
unassigned |
1
0 |
| 1.20.4.3 | Tuberculosis |
27417938 |
Redox chemistry of Mycobacterium tuberculosis alkylhydroperoxide reductase E (AhpE): Structural and mechanistic insight into a mycoredoxin-1 independent reductive pathway of AhpE via mycothiol. |
therapeutic application
unassigned |
3
0 |
| 1.20.4.3 | Tuberculosis |
28620052 |
The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis. |
therapeutic application
unassigned |
1
0 |
| 1.20.4.3 | Tuberculosis |
32158439 |
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug. |
therapeutic application
unassigned |
1
0 |
